The study is preliminarily planned to start in Spring 2020 after receiving permission from the Ethics Committee in all countries.
The proposed study is an observational study with no interference with the patient’s routine care, which is in accordance to the good clinical practice and no research-related interventions. Therefore, no ethical concerns are expected and ethical approval may not be required in some centres. However, where ethical approval is required, this approval must be obtained before the start of inclusion.
A template that can be used for your application to the Ethics Committee:
Each participating centre must report to ESAIC all the steps of Ethical submission and approval or notification, using the completed Approval Documentation Coversheet, to be signed sent to ESAIC with proof of approval/notification (local language is OK), by scan to email@example.com
If it could help you in your ethic approval process to have the approval of another centre of your country, please note that at least one Ethic approval has been received in the following countries:
Australia, Bosnia and Herzegovina, Bulgaria, Croatia, Denmark, Egypt, France, Germany, Greece, Iceland, India, Italy, Japan, Kosovo, Latvia, Libya, Mexico, Moldova, Norway, Slovenia, Poland, Portugal, Romania, Russia, Serbia Switzerland, Turkey, United States.